Diabetes drug's new weight loss formula fuels cost-benefit debate – Daily Montanan

A new drug that was developed to treat diabetes has also shown promise for weight loss leading some to question the cost-benefit of such medication.

Related Keywords

Maryland ,United States ,Toronto ,Ontario ,Canada ,Massachusetts ,Americans ,American ,Fatima Cody Stanford ,Sean Wharton ,James Gelfand ,Phylander Pannell ,Novo Nordisk Wegovy ,Michael Bachner ,Steve Pearson ,Industry Committee ,American Medical Association ,Institute For Clinical ,Drug Administration ,York University ,Harvard Medical School ,Novo Nordisk ,Massachusetts General Hospital ,Mass General ,Reduce Obesity Act ,Economic Review ,